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Abstract
The unprecedented COVID-19 pandemic highlights the need for portable,
sensitive, and accurate biosensors. Here, a novel biosensor that takes advantage of localized
surface plasmonic resonance (LSPR) through unique nanoscale geometries was fabricated
for sensitive detection of biomarkers. The formation of an adaptable system capable of
combining with other sensing methods, such as CRISPR-Cas13a assays, allowed for the
detection of specific targets to be realized. In this system, streptavidin-coated gold
nanoparticles (GNPs) hybridize with single-stranded RNA (ssRNA) before binding to the
surface of gold nanomushrooms (GNMs). Through LSPR enhancement, this binding event
produces a red shift in the resonance wavelength peak due to changes in the refractive index
surrounding the GNMs. Various concentrations, shapes, and diameters of nanoparticles
were investigated to determine the greatest possible resonant shift. Through this work, the
use of streptavidin-coated 40 nm AuNPs produced the greatest redshift at ~30 nm for
concentrations greater than 500 pM. Packaged in a microfluidic cell, the device offers a
novel strategy for the detection of biomarkers with minimal sample preparation and rapid,
label-free detection. Expanding this process to include CRISPR-Cas13a proteins
incorporates the advantage of collateral cleavage which further enhances the sensitivity of
LSPR, a critical and far-reaching bottleneck specifically of concern in label-free
biosensing.
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1.0

Problem Introduction

1.1 Introduction to Molecular Diagnostics
In the modern era of disease detection and treatment, therapeutics, and risk assessment,
molecular diagnostics have proven to be a necessity [1]. This topic envelops a variety of
techniques that combine medical testing and the science of molecular biology by observing
biomarkers found in the genome or proteome of a virus or organism. A molecule or genetic
sequence that is specific to the desired target and is easy to detect at a low cost comprises
the essential components for optimal biomarkers [2]. Common biomarkers include proteins
[2], nucleic acids such as DNA and RNA [2, 3], and antibodies [3], depending on if the
proteome or genome is being analyzed. Current diagnostic methods exist for testing both
the genome and the proteome, with tools such as mass spectrometers [2, 3], microarrays
[4], and polymerase chain reactions (PCR) [1, 5].
Mass spectrometers are a common molecular diagnostic method, available in a variety
of sizes and price ranges allowing a wide range of people access to the tool [2]. A mass
spectrometer works by vaporizing a sample, then sorting the resulting ion vapor by massto-charge ratio and plotting against the intensity or frequency of the specific ratio value.
To achieve this, the spectrometer is comprised of three main components, the ion source,
mass analyzer, and detector. The ion source is responsible for converting the molecules
from the sample into ions that are capable of being sorted and detected by the other main
elements. There are several leading methods for ionization such as the electrospray
ionization (ESI), which ionizes molecules from solution at a high voltage, or the matrixassisted laser desorption/ionization method (MALDI) that creates ions through the use of
an anchored solid matrix which promotes adsorption of the molecules and causes them to
1

crystalize along the surface. These methods are similar to each other as shown by the
examples in Figure 1. Once these crystals come into contact with a laser, they undergo
sublimation to form the ion vapor [2]. These techniques are both considered to be state-ofart ion sources for their ability to ionize small sample sizes on the order of micrograms, as
well as macromolecules like proteins. The ability to ionize proteins allows for the
sequencing of proteomes, something alternative ion sources fail to achieve.

b)

a)

Figure 1: Examples of (a) ESI and (b) MALDI ion sources [2].
Used under CC BY / Cropped from original.
The mass analyzer component is responsible for the separation and sorting of ions
resulting from the source by their mass-to-charge ratio. One of the common mass analyzers
used in microsystems is a time-of-flight (TOF) unit [3]. In this system, ions are separated
based on their kinetic energies and velocities, where ions of identical charge have the same
kinetic energy. This system can be insensitive to macromolecules since they would require
an acceleration of tens of keV for a reasonable signal to be obtained using a MALDI ion
source [3]. Instead, Fourier Transform (FT) analyzers are often used to combat this issue.
For this unit, charged particles are sent through a magnetic field, thereby inducing a circular
trajectory on the ions due to the Lorentz force [3]. The frequency of the rotation can be
measured and assigned to a specific mass value. The detector component used alongside
2

an FT system allows for the detection of multiple signals at once, which results in less noise
and allows smaller peaks to be further analyzed. These units are extremely sensitive and
can manage high throughput due to the multiplexed detection but come with the caveat of
having a higher cost when compared to TOF systems.
Microarrays have seen a growth in popularity as a method for molecular diagnostics
due to their usefulness in the mapping of genomes [4]. This method is a derivative of labon-chip devices, which are extensively used for multiplexed detection. Typically built on
a solid substrate, such as glass or silicon, the arrays are capable of testing microquantities
of biological materials. These arrays can be used to bind DNA or RNA probes with specific
nucleic acid base sequences to the surface of the device [6]. The attached strands can be
labeled with particular particles such as quantum dots or fluorophores to assist in detection.
Following hybridization with the device, these label molecules will release an intensity
signal proportional to the concentration of immobilized DNA or RNA strands in a given
area [4]. This technique can be used to uncover gene expression or to identify single
nucleotide polymorphisms (SNP) through the DNA or RNA hybridization process [4].
Since hybridization would only occur when the desired target is bound to the surface, no
signal is reported when the target is absent from the sample. These devices can be combined
with other diagnostic methods, such as mass spectrometers or fluorometers, to detect the
fluorophores released from the hybridized reporter probes.
PCR is another primary method for molecular diagnostics [5, 6]. These reactions give
the ability to replicate specific segments within a DNA strand using a DNA-polymerase
enzyme. This enzyme is responsible for producing a complementary DNA (cDNA)
sequence that matches the segment desired to be reproduced [5]. The complementary
3

sequence is known as a “primer” and is capable of producing billions of replicates of the
desired target. Through amplification of the desired segment it becomes easier to identify
and diagnose diseases found in the genome, as well as test for the presence of various other
organisms or viruses in a sample. PCR is most valuable when used alongside other methods
because of this ability to duplicate segments. The replication increases the concentration
of the target within a sample, and therefore amplifies signal peaks to values greater than
instrumental noise in many instances. This diagnostic method also makes observation of
gene expression easier to achieve, where it may be difficult to know the role of certain
sequences within a nucleic acid [5]. Due to the reproduction and wide-reaching
capabilities, PCR methods have come to be known as the gold standard in molecular
diagnostics.
1.2 Overview of Point of Care (PoC) Devices
In the face of our current pandemic with the SARS-Cov-2 virus variants affecting
people on a global scale, the importance of rapid testing and diagnostics is apparent [7].
Multiple molecular diagnostic techniques have been used in the detection of viruses, along
with the previous applications mentioned. But mass spectroscopy and microarrays are not
often used in diagnosing various diseases. This is because many of the molecular diagnostic
techniques are inefficient due to their bulky and expensive equipment, often requiring
extensive prior knowledge of the process or trained laboratory workers to operate. A
portion of these techniques require a standalone lab due to the size and cost of the
instruments which affects the global availability of the techniques. This makes the process
unfavorable and hard to scale to the level required for a pandemic-sized issue, highlighting
the need for an effective PoC device.

4

PoC tools encompass a vast group of
devices that are used for a variety of
applications [6]. For instance, devices
capable of detecting pathogens in water,
blood samples, saliva, urine, or other fluids
exist and are commonly utilized [5, 6, 8]. Figure 2: Typical structure of PoC device [6].
These devices can be constructed to test for Reprinted with permission from Gubala et al.,
2012. Copyright 2012 American Chemical
both proteins and nucleic acids, as well as
Society.
many other molecules and pathogens, much like molecular diagnostic techniques. PoC
devices are even capable of containing select molecular diagnostic methods such as PCR
[5, 6]. The ability to duplicate DNA sequences makes these devices attractive for their high
sensitivity and selectivity, but at the cost of longer response times and higher costs
associated with the PCR amplification [6]. PoC devices are defined by their ease of use
and compactness which is illustrated in Figure 2. Their ability to be used practically
anywhere, requiring only microsamples to provide accurate results is another crucial
advantage of PoC systems. This is referred to as “near patient” testing. Since the goal of a
PoC device is to be able to be used in vitro with minimal knowledge of the process, this is
a big advantage over bulky or complex molecular diagnostic techniques like mass
spectroscopy [6]. In order to be applicable for at-home testing, PoC tests need to be
elementary in operation, meaning they are processes that can be self-administered by
patients or consumers. As a result of the current pandemic limiting travel and gatherings,
among other things, a test that can be administered at home or without the presence of
medical professionals helps to prevent any further spreading of the disease and lower the
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response time in isolating or treating the virus [6]. Limiting contact with infected
individuals is paramount to slowing the pandemic and with the use of PoC devices it
becomes a more achievable goal.
1.3 Discussion on Localized Surface Plasmon Resonance (LSPR)
An emerging technology for in-depth nanoscale detection is LSPR. This method
provides a replacement for processes previously utilizing PCR as an amplification
technique. LSPR allows for label-free detection of molecules bound to the surface of
nanoparticles or nanostructures through shifts in optical resonance due to changes in the
surrounding refractive index (RI) [8]. This technique provides a real-time detection method
that can be used for any target that can be immobilized on the surface of the substrate.
LSPR is capable of this advantageous detection by enhancing incident light waves that
travel through “hot spots” between resonating nanoparticles of specific materials, as shown
below in Figure 3. The resonating particles used for the enhancement of light must have

Figure 3: Demonstration of a "hot spot" in a dimer system [9].
Reprinted from Analytica Chimica Acta, Volume 706, Eleonora
Petryayeva, Ulrich J. Krull, Localized surface plasmon resonance:
Nanostructures, bioassays and biosensing - A review, Pages 8-24,
Copyright 2011, with permission from Elsevier.
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controlled dimensions since minor differences can affect the sensitivity and resulting
resonant peaks observed [8]. Coinage metals, often gold, silver, or copper, are typically
used in the fabrication of LSPR substrates due to their light adsorption strongly occurring
in the visible region of the spectrum, among other advantages [10]. Nanoparticles made
from coinage metals also exhibit high mobility of valence electrons that can be easily
observed with common detection instruments. Their free electrons undergo an oscillatory
effect due to the positively charged nuclei that resist the relaxation of these electrons. Due
to the constant movement of electrons, an electric field forms around the nanoparticles
when electrons are excited by the presence of incident light [10]. For this event to occur,
the frequency of these incident photons must match the frequency of the valence electron
oscillation which in turn, produces the surrounding electric field [10]. The use of gold is
also popular as it is fairly chemically inert, meaning a gold substrate would be less likely
to react with the surrounding solutions and media. The variety of chemicals that gold can
resist opens up the device to more opportunities and expands the applicability of the
system. Other than the materials used in the substrate, the particular optical resonance peak
at certain wavelengths depend on their surface conditions as well. This includes the binding
of citrate molecules, which aid in preventing aggregation of aqueous nanoparticles, or
streptavidin molecules among various other desirable surface chemistry changes. The
streptavidin molecule forms an ultra-strong covalent bond with biotin molecules which can
be used as end groups on DNA or RNA strands.
LSPR is a variation on surface plasmon resonance (SPR), operating on similar
principles. The greatest difference between the two methods is the location of where the
plasmons are excited. SPR utilizes propagating surface plasmons which are excited on thin
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metallic films, while LSPR will excite localized surface plasmons on nanoparticles, which
can come in a variety of forms [11]. LSPR shows enhanced sensitivity to localized electron
fields surrounding the particles compared to the resonance on metallic substrates from SPR
methods. The increased sensitivity of LSPR techniques is further aided by dark-field
imaging [12]. Dark-field images are created by scanning for the intensity of scattered light
resulting from incident photons across the gaps between nanoparticles or at specified
biosensing locations [12]. LSPR can be sensitive enough to detect even single-molecule
binding events on the surface of a nanoparticle by observing the shift in the RI around the
particle in the presence of scattered light [12].
LSPR can undergo both radiative and non-radiative decay following excitation by
incident light. Radiative decay is a result of the scattering of resonant photons, while nonradiative decay is directly caused by Landau damping [10]. Landau damping is a unique
effect that occurs when the resonant surface plasmons decay into electron-hole pairs [13].
The formation of these electron-hole pairs is at the highest rate in the previously mentioned
“hot spots” located between adjacent nanoparticles [14]. Through the coupling of
nanoparticles to form dimers, these “hot spots” or areas of enhancement are created. Light
passing through these areas amplifies the resulting wavelength signal to approach
intensities millions of units higher than the original signal [14]. With the further addition
of nanoparticles to form larger multimers, the oscillation of the particles is important in
increasing the efficiency of “hot spots” in creating electron-hole pairs. The enhancement
within dimers is best seen when the particles are oscillating in phase, which means in the
same direction at the same speed, as opposed to against each other. At higher levels such
as trimers, multimers, and up to vast arrays, the number of possible resonant configurations
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increases which can change the locations and intensities of the various “hot spots.” With
more particles, such as in an array, the enhancement effects resulting from “hot spots” can
increase even further with specific particle resonance. These electron-hole pairs have many
applications other than use in LSPR making these systems valuable. One such application
for these pairs is inorganic semiconductors, where the electron-hole pair has high mobility
and can distribute a charge through a substrate’s lattice structure. Both radiative and nonradiative decay processes have exciting applications as well, particularly in the excitation
of certain adsorbates and charge transfer from nanoparticles to the adsorbates. The
excitation of other molecules by resonant photons is limited only to molecules that possess
an energy gap between the highest occupied molecular orbital (HOMO) and the lowest
unoccupied molecular orbital (LUMO) that is identical to the energy of the photons used
in excitation [10]. This charge transfer system is used as the driving mechanism for many
photoreactions. The electrons from the electron-hole pairs will move into the LUMO band
of the bound molecules creating negatively charged particles which help to stabilize and
drive certain dissociation reactions [10]. Electron-hole pairs have also been shown to
produce photothermal effects when the hot electrons relax [14]. Therefore, these LSPR
systems can act not only as a detection system for biomolecules, but as a catalyst for
reactions by producing electron-hole pairs that accelerate the kinetics of a reaction in
presence of incident light waves. Since these mechanisms can be the driving steps in
several other reactions, the application of LSPR expands into fields that might not seem
related to biosensing.

9

1.4 Synopsis of CRISPR Technology
Alternate methods exist for viral
detection of DNA other than PCR
amplification, in the form of clustered
regularly interspaced short palindromic
repeats (CRISPR). Through the study of
bacteria and archaea, CRISPR and
CRISPR associated systems (Cas) were
first observed [15]. The CRISPR-Cas
complex has become one of the fastest

Figure 4: Diagram for CRISPR-Cas12a (Cpf1)
complex attack on dsDNA target [18].

growing fields with vast applications

Used under CC BY / Cropped from original.

across several aspects of microbiology. The versatility and specificity of these systems
allow for the detection of both DNA and RNA molecules, as well as testing for SNP and
single nucleotide variations (SNV) on a smaller scale [16, 17]. In the presence of a
particular DNA or RNA molecule, CRISPR tools can be specially designed for detecting a
specified sequence within the strand. This is often achieved through a single guide RNA
(sgRNA) in conjunction with a Cas protein to either break a double-stranded DNA
molecule (dsDNA) in order to bind to the target strand, or to bind with a ssRNA at a
particular location [17]. The sgRNA portion is formed by combining CRISPR RNA
(crRNA) and transactivating RNA (tracrRNA) [19]. Therefore, the sgRNA is highly
customizable as the nucleotides contained within the two RNA materials can be adjusted
for various target sequences in a wide array of applications [17]. The other component in
nucleic acid detection is the Cas protein. Nearly all types of CRISPR-Cas systems contain
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Cas1 and Cas2 proteins. These two are responsible for the adaptation of the infecting or
target DNA and are spacers in the CRISPR locus at the leading end of the complex [20].
In order to aid the sgRNA in recognition of the particular target sequence, a protospaceradjacent motif (PAM), or a PAMmer in the case of ssRNA, is used [20]. The PAM exists
adjacent to the target region on the complementary strand of the target molecule which
promotes the Cas protein’s hybridization with the target. For positive detection of binding,
labeling the target strand with fluorescence particles at one end is common practice. These
fluorophores are released once hybridization occurs, producing a measurable signal. This
can also be combined with quenching end labels which allow for easier detection of
released fluorophores by covering unbound probes. CRISPR-Cas systems can also be used
in the detection of point mutations or SNV in DNA or RNA strands when looking for a
particular nucleotide base change [21]. The Cas proteins lack sensitivity to find randomized
variations since the target sequence would fail to match the sgRNA of the system. In
looking for diseases caused by SNV, such as sickle cell anemia, CRISPR systems can
identify and potentially replace the abnormality by looking for the complementary strand
to the point variation which avoids the reduced sensitivity [21]. This is achieved through a
nicking process of the endonuclease, where once the system identifies the target sequence
with the abnormality, the protein breaks the side of the dsDNA containing the wrong base
pair to mark it for replacement by natural cell processes for DNA repair [21]. This process
shows a promising future for further development that could lead to the cure of diseases
and ailments once thought to be permanent afflictions.
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Due to the high number of distinct CRISPR-Cas systems discovered, they were
separated into two overarching classes each containing three subdivisions referred to as
types. The classes are defined by the effector complex within the system where class 1
arrangements contain multiple crRNA effector complexes, typically ranging from four to
seven Cas proteins [22]. Type 1 and 3 subsystems are similar and are both contained within
class 1 but utilize different assemblies to achieve their function. Type 1 systems organize
the effector complexes into a CRISPR-associated complex for antiviral defense (Cascade)
complex, which is a combination of multiple Cas proteins. Meanwhile, type 3 subsystems
apply Csm or Cmr proteins to achieve nucleic acid cleavage [15, 19]. Class 2 systems use
single-effector proteins which differs from class 1 complexes where multiple Cas
molecules are used as illustrated above in Figure 5 in the effector region. Type 2 is the
most well-defined subdivision of class 2, containing the single complex Cas9 protein. This
protein is comprised of two nuclease domains, HNH and RuvC, which are responsible for
target displacement and sequence cleavage [15, 22]. Type 5 systems are a more specific
classification when compared to type 2 since this division of proteins is defined by a single

Figure 5: Differences between Class 1 and Class 2 CRISPR systems.
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RuvC endonuclease domain, such as Cas12 proteins [19]. The majority of CRISPR-Cas
systems are proficient only in the cleavage of DNA with the exception to type 2, 3a, and
3b which have the capability to target RNA strands, and class 2 type 6 systems that contain
two HEPN domains (Higher Eukaryotes and Prokaryotes Nucleotide-binding) which
contain Rnase activity for RNA strand targeting and cleavage [22]. These two domains are
contained within a single effector protein known as c2c2 or Cas13a and are capable of
targeting ssRNA which is identified by complementary crRNA strands [15]. Cas13a also
has the unique advantage of non-specific cleavage following the binding and cleavage of
the target strand [17, 21]. This property allows CRISPR-Cas13a systems to have potentially
higher signal amplification when identifying target sequences or mutations within them.
By adding RNA reporter probes into the solution with the test sample, a rapid response
detection method is possible. If the reporter probes are cleaved through the collateral
cleavage of Cas13a, that would imply that the target strand was present in the solution since
the non-specific cleavage only follows the degradation of the target sequence [17]. This
idea can also be used for the detection of point mutations where if the target strand contains
a variation in the nucleotide sequence that is different than the gRNA, there will not be
target cleavage and therefore, no output signal from the reporter probes since they will not
be degraded by the CRISPR-Cas complex [21].
1.5 Combining CRISPR and LSPR Biosensing
CRISPR and LSPR technologies offer encouraging results in advancing the capabilities
of PoC devices. Currently, a tool combining the advantages of both methods has yet to be
developed. Light enhancement that results from an LSPR plasmonic device offers a labelfree detection method for analytes that can bound to the surface.
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Here, preceding the target nanoparticle
being attached to the nanostructures, a
CRISPR system is used to cleave ssRNA in
the presence of SARS-CoV-2 in solution
which would free AuNPs for later binding to
the surface of the plasmonic chip. The Cas
protein would cleave the nucleic acid if the
solution contained the specified target
sequence described above. By comparing the Figure 6: Sensing of target DNA by LSPR
enhancement on gold nanomushrooms.
peak of the absorbance spectrum before the Reprinted with permission from Dr. Nikhil
Bhalla and Professor Amy Shen
CRISPR system was introduced to a shift in
(Micro/Bio/Nanofluidics Unit OIST).
the peak value can be observed indicating the AuNP was present on the surface and the
target was in solution. This combination of biosensing methods offers high sensitivity and
specificity in detection of nucleic acid sequences. As well as offering fast turnaround times
in PoC devices, this pairing of LSPR and CRISPR systems provides consistent and
repeatable results. The combination of label-free detection methods, the ability to evaluate
dilute samples, and the small size requirement for LSPR substrates, lead to a portable PoC
device capable of use as a ‘near-patient’ device.
Through the combination of both LSPR and CRISPR techniques, a portable PoC device
capable of high sensitivity detection of ultra-dilute samples in a cost-effective manner
became achievable. For this process, viral RNA molecules were cleaved off-chip to release
AuNPs to the surface of the plasmonic chip. These are bound to the AuNM substrate via a
direct addition protocol which offers a linker-free method for binding. The plasmonic chips
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contained approximately 106 nanomushroom structures on a 1 cm2 glass chip. These
nanomushrooms are crafted from silicon dioxide pillars, capped by gold nanoparticles
which are capable of detecting zettamolar quantities of the target analyte by taking
advantage of the signal enhancement resulting from LSPR between caps [23]. The threedimensional structures provide greater surface area allowing for higher bonding of the
analyte system. The plasmonic chip was adhered to a glass substrate and covered by
specific PDMS mold before the addition of the nanoparticles occurred. Through the
addition of AuNPs, it was observed that the peak resonant wavelength underwent a gigantic
redshift of 30 nm. Combined with the label-free advantages of LSPR and the size of the
substrate the system is low cost and highly portable, while still maintaining high sensitivity
and the ability for real-time detection. This is further exemplified by the CRISPR
combination which used collateral cleavage to increase the sensitivity of the system,
without requiring amplification of any components.

15

2.0

Literature Review
The accompanying literature review section outlines the basic techniques used in

combination that led to the detection of viral DNA on gold nanomushrooms through the
first device to combine CRISPR cleavage techniques and LSPR signal enhancement. This
includes the development of PoC systems, and the many accompanying techniques utilized
for detection. As well as the incorporation of LSPR into PoC devices in conjunction with
CRISPR systems for biosensing applications. The following literary review section opens
with a review of nucleic acid detection techniques.
2.1 Introduction to Nucleic Acid Detection (NAT)
The expansion of studies in nanoscience and microbiology has led to the growing
use of biomarkers in testing. As previously stated, biomarkers can range from antibodies
in blood to exosomes containing proteins and nucleic acids like DNA and RNA. The use
of biomarkers provides healthcare professionals with the advantage of early disease
detection before symptoms begin to show [8, 24]. This can include many neurological
diseases, as well as internal issues with nearly all bodily systems. Biomarkers are also used
for studying gene expression where hereditary diseases and ailments are often screened for.
The different uses of biomarkers lead to most biomarkers falling into two major categories,
biomarkers of exposure and biomarkers of disease [24]. Exposure markers are used to
analyze the effects of environmental conditions and risk factors on an organism [24]. By
incorporating samples of blood, hair, or other biomarkers, the detection of toxins and their
concentrations can be used to determine the risk and health concerns posed by the foreign
substances. Biomarkers of disease are crucial in detection of ailments in preclinical stages,
which allows earlier treatment while the disease is still in an infantile stage and potentially
16

poses a lesser threat to an individual [24]. Screening for disease biomarkers is common
practice and is used in the detection of many illnesses such as Alzheimer’s disease [24],
diabetes and kidney disease [6], and several other neurological disorders [24].
For any biomarker to be considered for use, it must be able to provide relevant
information in a consistent manner. The applicability of information supplied by
biomarkers is crucial as the information must provide valuable indicators or results for
future steps to be taken. Otherwise, the biomarker provides no advantage in disease
detection. The repeatability of results is also decisive in the incorporation of a biomarker
into PoC tools. Producing false positives is a concern since that generates misleading
conclusions which can prove to be harmful where medication would be supplied [25].

One classification of biomarkers that is critical in disease detection and risk
assessment is nucleic acids [26]. The primary biomarkers encompassed by nucleic acids
are DNA and RNA structures. Nucleic acids are crucial because they are responsible for
containing all the information involved in gene expression. Both DNA and RNA are
responsible for the creation of proteins in the body. The information contained within their
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makeup can be used in a variety of ways as biomarkers. They can be observed to scan for
abnormalities in gene sequences or to identify foreign nucleic acids belonging to other
organisms or viruses [26]. There currently exist an extensive quantity of methods for the
detection and applying DNA and RNA as a biomarker. This includes sequence recognition,
where a set order of nucleotides in a specified order is built on a probe to capture the
complementary strand of the target nucleic acid [27]. Other methods include labeling
probes as previously described, where fluorophores or quantum dots can be attached to the
nucleic acid [27]. Once bound to the target strand or cleaved by a CRISPR system, the
fluorescent particle is released from a quencher and emits a detectable signal in a
fluorometer. The quenching particle is responsible for suppressing the signal released by
the fluorophore while still bound to the probe in close proximity to the fluorophore.
PCR techniques are commonly referred to as the gold standard in nucleic acid
analysis since it is capable of detecting single nucleotides in extremely dilute solutions
[27]. As previously stated, PCR systems are molecular diagnostic tools used to replicate
sequences of nucleic acid in the presence of an enzyme. PCR systems function in three
steps. First, the dsDNA is denatured at a high temperature forming two ssDNA molecules
[28]. Following the denaturing process, one oligonucleotide primer binds to each strand
adjacent to the target sequence through an annealing step [28]. Finally, the DNA
polymerase enzyme binds the corresponding nucleotides to the free locations on the ssDNA
bordering the primer until two complete dsDNA molecules exist [28]. This process can be
cycled and repeated for an exponential replication of DNA strands. Amplification in the
number of nucleic acids creates more biomarkers of identical composition making SNV
easier to detect or providing a larger sample for use in a less sensitive system. Reverse
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transcription PCR (RT-PCR) is a variation on PCR techniques, employing messenger RNA
(mRNA) instead of dsDNA for the PCR amplification [29]. Instead of denaturing DNA
strands, the mRNA undergoes synthesis of a cDNA strand in the presence of an enzyme
and a single oligonucleotide primer [30]. The enzyme named reverse transcriptase, is
responsible for the construction of the cDNA onto the RNA starting at the bound primer.
Primers can vary in structure from non-specific to gene-specific in their binding sites. A
nonspecific primer offers the advantage of being able to amplify multiple mRNA strands
in the same solution since the primer is able to adjust nucleotides to match the RNA
sequencing [30]. The gene-specific primer is valuable for its ability to increase the
specificity of the amplified strand and decrease systematic noise that can arise from
variations in mRNA sequencing in solution [30]. One popular improvement made to PCR
methods is quantitative or real-time PCR (qPCR). In qPCR, fluorescent dyes are added to
solution, which have an affinity for binding to dsDNA resulting from hybridization with
the target sequence [26]. Therefore, with the amplification of the target sequences, more
hybrids will form and the number of binding sites for the dyes will increase, producing a
signal with greater intensity over time [26]. Quantitative RT-PCR (qRT-PCR) has an
identical process to RT-PCR with the addition of fluorescent dyes onto the RNA molecules
on the end opposing that of the primer [26]. Once the enzyme begins building the cDNA,
the fluorescent dye will be cut from the RNA strand, freeing the dye from the quencher,
and releasing a detectable signal [30]. As more probes are broken the strength of the signal
increases in intensity allowing for real-time monitoring of the amplification and PCR. The
process of qPCR and qRT-PCR are only able to be used as semi-quantitative due to the

19

amplification bias that can occur through SNV in PCR techniques [26]. Still, the qPCR
technique has become known to be the gold standard for nucleic acid analysis.
2.2 Use of PoC Systems for NAT
Regardless of PCR systems being the gold standard for NAT, they are inefficient for
use in PoC devices. This is due to the bulky nature of current tools and the required sample
preparation before testing for current methods. The complexity and resource requirements
limit where PCR-based techniques can be employed, namely centralized laboratories or
hospitals with proper equipment and personnel [31]. The reaction demands a
comprehensive understanding of the process at all three phases: sample preparation,
denaturation and amplification, and detection. Sample preparation is crucial in the
efficiency of PCR and demands time and resources to isolate nucleic acids. PoC systems
trying to utilize PCR often require high concentrations of starting material which can be
hard to obtain, especially for dilute biomarkers [32]. They are also highly susceptible to
false positives and negatives due to improper sample preparation. Most preparation
techniques are manually performed allowing for more errors and contaminants to limit the
amplification and detection of the target sequences. Contaminants have the possibility to
function as inhibitors that constrain the polymerase, or other enzymes used, in the
construction of complementary molecules on the mRNA or ssDNA [31]. In RT-PCR, the
isolation of RNA can prove difficult. RNA can be sensitive to changes in pH affecting the
concentration of the resulting nucleic acid sample [30]. Amplification poses a challenge in
PCR along with sample preparation. As target sequences get amplified, so do errors or
mutations hidden within the segment. In qPCR, variations in the number of unique DNA
sequences can cause a fluorescent signal to vary in intensity resulting from improper
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cleavage of probes, therefore misrepresenting the actual quantity of copies made by the
reaction [30].
In order to improve upon PCR for integration into microfluids, isothermal
amplification was employed as an alternate PoC device. It was more compact and offered
a cheaper alternative without the addition of heating [31]. This opened the possibility for
PCR to be used on PoC devices in combination with new detection methods. Isothermal
amplification still had drawbacks making alternative methods favorable in microfluid
analysis. Extensive sample preparation is still required before introduction to the system.
At isothermal conditions, the limit of detection (LOD) is too high with some methods
causing poor sensitivity [33]. To be able to use this new method for NAT, advancements
need to be made in improving the reliability of results and the integration of all aspects into
a single, portable device.
Other technologies for NAT in PoC devices include bioluminescence amplification
[34, 35, 36], probe-based assays [34, 35, 37], or electrochemical microarrays [38, 39].
These techniques are often categorized based on their detection method. The groupings
include hybridization assays, sequence-based testing, and trapping methods, with many of
these techniques combining aspects of multiple categories [35]. Bioluminescence or
fluorescence is commonly used in a multitude of systems, as it provides quantitative and
real-time updates on the status of a device. This allows for a higher sensitivity in testing
and a reduction in the size of micro assays [36]. Probe-based assays work by immobilizing
a single-stranded oligonucleotide chain, typically ending with a label or fluorescent dye,
onto a device substrate or nanostructure [34]. These probes then hybridize in the presence
of the target nucleic acid and produce a detectable signal based on the label utilized. DNA
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probes are often used in conjunction with other techniques, such as amplification since the
probes are highly customizable. The blending of probe-based assays allows for PoC
devices with higher sensitivity and lower detection limits than ordinary hybridization tools.
As shown by Yang et al. in Figure 8, utilizing an enzyme capable of facilitating recycling
amplification in the presence of a target sequence that then hybridizes with a fluorescent
probe, provides a highly sensitive system that is capable of producing rapid results in realtime [37]. This is one use for fluorescent probes in detection.
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Alternatively, probe assays can be used in electrochemical systems instead of in
combination with amplification methods. Devices that employ electrochemical systems are
highly sensitive causing an increased efficiency in sample detection. Through the
immobilization of DNA probes on the surface of a transducer, an electrical signal is
produced indicating the presence of the target strand [38]. Once the DNA duplex is formed
between the probe and target sequence, electroactive indicators bind producing an
increased current signal. The indicators are commonly used alongside enzyme or redox
labels that preferentially bind to the target strand over the ssDNA probe [38]. For these
systems, the surface condition is crucial. The density or packing of the probes onto the
substrate or nanoparticles can affect the selectivity of DNA binding and minimize nonspecific adsorption [38, 39]. Single-base mismatches can be detected through proper
selection of the probe. It has been shown that
peptide nucleic acids (PNA) provided higher
sensitivity in a biosensor when compared to
certain ssDNA probes [40]. As well as being
a label-free detection method that does not
require amplification [40]. PNA probes are
often

used

for

single-base

mismatch

screening due to the instability of PNA and
target DNA hybrids when compared to DNA

Figure 9: Changes in surface condition
on a transducer following hybridization
for detection of a target [38].

Reprinted from Biosensors and
Bioelectronics, Volume 21, Joseph Wang,
probes and target hybrids [39]. Therefore, in
Electrochemical biosensors: Towards
point-of-care cancer diagnostics, Page 2,
the presence of a mutation, a stronger signal
Copyright 2005, with permission from
Elsevier.
is produced since the PNA/DNA target hybrid
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will degrade which implies the mismatching base pair is present. This is key to the early
detection of diseases like cancers, which are caused by genetic mutations [38].
2.3 Role of LSPR in PoC Devices
Incorporating nano-biosensors into PoC devices gives the advantage of real-time
detection of nucleic acids. LSPR systems offer an advantageous alternative to previous
detection methods such as electrochemical and qPCR techniques. The integration of
nanoparticles smaller than the incident light wavelength as the main component for
detection allows for the miniaturization of PoC devices. This allows for higher portability
of devices used for on-site testing. Compared to many PCR tools that require large-scale
equipment and a centralized testing lab, LSPR devices offer a quick turnaround after
experimenting. The advantage of LSPR techniques in PoC devices relies on four principles
[41]. One of the core principles for PoC devices with LSPR systems is the ultrahigh
sensitivity in screening caused by the changes in the RI. Relying on the interactions
between light and metallic nanostructures, the dielectric properties surrounding the
particles vary with their environment [41]. The other principles include the specific
detection of target analytes, the integration of sample treatment and analysis, as well as the
portability, automation, and ease-of-use help to make a portable PoC device [41].
Automation in PoC is aided by the miniaturization of the LSPR detection system. The less
area required for detection allows for more space to be allotted for microfluid separation,
a common issue with PoC testing. Designing a device capable of autonomously separating
target analytes from the rest of the sample eliminates human error from sample preparation
[42]. Plasmonic systems provide a simpler method in preparation due to the ability for
label-free detection of nucleic acids which simplifies the preparation to only isolation of
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nucleic acids in most cases. Detection of the target analyte is simplified by LSPR where
only two measurements are required. By comparing a baseline spectrum of the
nanoparticles to a spectrum after the addition of the sample, detection of single molecules
or nucleic acids can be observed. Incorporating the LSPR technique, the intensity of the
resulting electric field is enhanced at the plasmonic resonance frequency, making minimal
peaks more pronounced above the noise [43]. Due to the shift in the RI by the binding of
target analytes to the surface of the nanoparticles, a red or blue shift in the peak of the
spectrum can be observed [44]. Devices employing LSPR substrates are made possible by
portable spectrometers, which allow for PoC devices to be more portable [42]. LSPR
systems also have the advantage of being insensitive to minor changes in the angle of
incidence of light since the light is directly interacting directly with the sample [42]. This
is in contrast to SPR methods, where the incident angle off the metallic film is controlled
and adjusted to ensure the greatest resonant signal [44].
Due to the growing interest in LSPR for PoC devices, distinct characteristics need
to be adjusted for specific sequences. For different applications, the nanoparticles used can
be constructed in different arrangements and densities. This can affect the RI sensitivity,
the surface decay length, the number of non-specific bindings, and the plasmon resonant
frequency that results [43]. Coinage metals are typically used for nanostructures, primarily
gold and silver due to their resonant wavelengths in the visible region. Copper and
aluminum are alternative metals to gold and silver that have been investigated for their
abilities in LSPR sensors [45]. They are often avoided due to their susceptibility to oxide
formation [45]. Silver offers higher intensities and sharper peaks in spectrum displays than
gold structures would [45]. However, gold is still the common metal used since it has
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greater chemical stability in nanoparticles for nucleic acid detection when compared to
silver particles [45]. Nanoparticles made from gold and silver can be fabricated in a number
of ways. Nanoparticle systems are typically in the form of a colloid, where the particles are
suspended in a liquid, or in the form of printed structures onto a substrate. There are many
lithography procedures and ion beam techniques, or chemical reactions from both organic
and inorganic reactants to form the nanostructures and colloids respectively [45, 46].
Suspended nanoparticles are often formed through reduction reactions, producing
a high volume of particles at a low cost [43, 45, 46, 47]. Techniques employing chemical
reactions to produce nanoparticles are often referred to as a bottom-up approach, where the
conditions and dimensions of the nanoparticles are determined by the reaction [45].
Typically, gold chloride is dissolved in water with a reducing chemical such as phosphorus
[46]. Synthesis by this method often requires stabilizing agents to prevent the nanoparticles
from aggregating and precipitating out of solution [48]. The stabilizers limit the van der
Waal’s forces between the nanoparticles and help to prevent oxidation [48]. Citrate is a
common example of stabilizers used for producing colloidal gold or silver. A number of
other wet-chemistry combinations are possible in synthesis of nanoparticles. Other than
reduction reactions, biological reactions have been shown to be able to produce inorganic
nanoparticles. Biological synthesis provides a nontoxic alternative to the synthesis of
particles through the use of algae, bacteria, and even some viruses [47]. These organisms
and viruses required controlled environments to operate in most cases, needing specific pH
values and temperatures to ensure the proper formation of nanoparticles [47]. Often neutral
pH values and ambient temperature conditions were sufficient for the reactions. The
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drawback to the nontoxic reactions is the formation time, which can range from one day to
five days for bacteria and fungi [47].
Both methods for colloidal metals can be altered to form a wide variety of shapes,
the simplest being a sphere. Most shapes are possible for nanoparticles, however
nanospheres, rods, shells, triangles, cubes, and stars are common configurations [46, 47].
Producing nanospheres is the easiest shape to achieve as it occurs naturally from wetchemistry. In one method to achieve the other shapes, micelles or hard templates as shown
in Figure 10, are formed to control and achieve the desired AuNP shapes from seeded
growth [48]. These molds are often used in the formation of nanorods [49]. To best control
the aspect ratio of nanorods, spherical nanoparticles are often planted inside the templates
to act as seed for promoting growth the rod
[49]. The process of using spherical shapes to
grow varying nanostructures is referred to as
seeded growth and can provide more
reproducible and exact shapes compared to
one-step growth [45]. The advantage of hard
templates allows for tighter control on the
size, while being adjustable for new lengths.
Micelles provide the better option for a larger
scale-up at the cost of weaker control on
aspect ratio [49]. Colloidal gold and silver can
be adjusted for a variety of applications with
the numerous methods for formation and the
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diverse configurations available making it a well-suited biosensing method for PoC
devices.
Construction of nanoparticles onto a substrate is an alternative method to
suspending nanoparticles in solution for LSPR detection. Methods for fabricating
nanostructures onto solid supports are referred to as top down techniques since the
structures are often chemically bound to the surface of a substrate [45]. Top down assembly
is better suited for creating larger quantities of samples by the nature of techniques used
[23]. Commonly used techniques included electron beam lithography (EBL) or focused ion
beam (FIB) etching and deposition [45]. These two techniques are highly advanced and
produce specific nanostructures that might not be possible in colloids such as nanodisks,
rings, and holes [45]. The techniques are expensive and limit the number of commercial
locations able to produce samples. Other techniques for lithography are possible such as
silanization, where metallic nanoparticles are immobilized onto the surface of a glass
substrate, offer cheaper alternatives to EBL and FIB tools [45]. Silanization is the process
in which a monolayer is formed on the surface of glass or silicon oxides which allows for
the binding of the metallic nanoparticles [50]. The substrate needs to be free of
contaminants for proper monolayer formation such that the hydroxyl groups are exposed,
and the monolayer can form [50]. This method has poor control over the density and spatial
distribution when compared to lithography and ion beam techniques but offers a simpler
and cheaper alternative for situations where packing dimensions might not be tightly
controlled.
New techniques combining both bottom up and top down approaches have received
significant interest in developing high-resolution nanostructures onto a substrate for LSPR
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biosensing. Combining both of these methods can limit the time consuming steps, such as
lithography, but maintain high accuracy and reproducibility. Etching techniques take
advantage of specific chemistries for the removal of coatings on a substrate that result from
lithography. Wet and dry etching methods show the capability to produce complex
nanostructures in pillar-like formations [23, 43]. Gold nanoparticles are used as a mask on
a silicon dioxide layer and prevent etching directly below them. Nanoislands or nanodisks
are common nanoparticles created for masks and act as caps protecting the layer below
from removal. The addition of an aggressive gas or liquid, such as sulfur hexafluoride, will
selectively remove silicon dioxide where the gold nanoparticles are not present resulting
in the pillar-like structures [23]. This creates mushroom-like features from the gold caps
with the silicon dioxide as the stem on a glass substrate. These nanomushrooms have been
shown to have extremely low limits of detection near 66 zM [23]. It has also been shown
that the nanostructures help to reduce nonspecific binding of DNA targets by 41% through
separation of the electromagnetic field of the substrate and the plasmonic structures [45].
These nanomushrooms provide a compact detection method suitable to fit into PoC
devices. The low limit of detection and high sensitivity to single molecule binding provide
a promising mobile device since small-scale and portable optical spectroscopy methods
can be employed for detection. As well as the ability for label-free detection, which further
simplifies a PoC device utilizing LSPR nanostructures.
2.4 Employing CRISPR for Sensing Methodologies
The role of CRISPR/Cas complexes in PoC devices provides a similar advantage to
LSPR biosensing. Comparable to how LSPR techniques can detect analyte samples with
single molecule sensitivity, CRISPR tools have the sensitivity to detect single base-pairs
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within a molecule of DNA. These systems offer rapid, low-cost testing of samples
containing attomolar quantities of target strands with ultrasensitivity [51]. Due to the
variety of Cas systems that exist and the customizability of CRISPR molecules,
CRISPR/Cas systems provide versatile NAT in PoC devices by being able to detect both
DNA and RNA from a variety of readout methods [51, 52]. Common detection methods
for CRISPR biosensing devices include colorimetric [51, 52, 53, 54], electrochemical [51,
52, 53], and fluorescent detection tools [51, 52, 53, 55]. These varying readout possibilities
increase the versatility and widespread use of CRISPR systems in PoC applications.
Electrochemical detection is well suited for use in CRISPR biosensing devices for its
ability to detect dilute samples without the need for amplification processes such as PCR
[51, 52]. As previously stated, a form of transistor is required to produce an electric signal
in response to a change in the surface condition of the transistor [38]. A common design
for electrochemical sensing is to use graphene field effect transistors [51, 53]. These
structures can immobilize dCas9, which has both nuclease domains deactivated, preventing
the CRISPR tool from cleaving target DNA strands [53]. As a result of the Cas9 complex
being deactivated, the CRISPR binds with the target DNA instead of cleaving it, causing
an increased concentration of charged molecules on the surface of the graphene, which
decreases the resistance of the system and changes the electrical signal obtained [53].
Systems utilizing the cleavage ability also exist where DNA strands labeled with reporter
molecules are immobilized onto the surface of a transistor [51, 53]. Introducing CRISPR
systems to the surface, the target strands will be cleaved resulting in a separation or
destruction of the reporter component which affects the electrical output.
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The use of colorimetric detection is popular alternative to an electrochemical method
due to its widespread accessibility [53]. This method of detection relies on a visible change
in color when exposed to a target analyte in the sample. For CRISPR samples this can be
used to identify particular sequences of interest [53]. Samples incorporating colorimetric
detection are often simple, easy-to-use devices that allow for broad application and robust
testing [52]. Pregnancy tests are common examples of colorimetric detection, which
employ lateral flow assays (LFA), instead of CRISPR systems, that immobilize target
antigens onto antibodies, resulting in a visible color change [52, 54]. Other than LFAs,
colorimetric detection can be easily employed in nanoparticle systems since gold
nanoparticles in solution undergo a color change when aggregating together [54]. This
detection method makes up the majority of commercial PoC systems available because
these assays can offer rapid testing in portable devices at a low cost. The shortcoming of
colorimetric systems is that they provide only qualitative responses from the resulting color
change, or the absence of one. In some cases, the intensity of the resulting color can provide
limited quantitative information, but that can be hard to measure and often require
additional detection methods to obtain valuable information.
Fluorescent detection methods work well in conjunction with CRISPR/Cas systems for
use in PoC devices. As shown in PCR technologies, the use of fluorescent particles can
allow for real-time detection and both qualitative and quantitative results, making them
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Figure 11: Demonstration for fluorescent detection by Cas12 and Cas13
cleavage [51].
Reprinted from Biosensors and Bioelectronics, Volume 165, Wang et al.,
CRISPR/cas systems redefine nucleic acid detection: Principles and methods,
Page 2, Copyright (2020), with permission from Elsevier.
desirable for use in PoC tests [34, 36]. Instead of amplification in PCR devices, early
CRISPR complexes incorporated fluorescence as shown in Figure 11 to detect the
presence of specific target sequences in DNA or RNA molecules [51]. One example system
is SHERLOCK, where fluorescence was achieved through quencher-labeled reporter
nucleotides that released a fluorophore following target binding by the Cas13a protein [52,
55]. This process allowed for signal amplification rivaling PCR processing at 10,000 times
greater than the original intensity, due to the adjacent cleavage ability of Cas13a and other
proteins such as Cas12 [17, 21, 53, 55]. The collateral cleavage in the presence of a target
sequence creates further degradation of the quencher probe, which causes higher turnover
in the target molecules [55]. This eliminates the need for amplification methods such as
PCR or isothermal amplification and will simplify point of care devices. Since the use of
fluorescence in combination with CRISPR systems drastically amplifies output signals,
detection of ultra-dilute samples becomes possible, making them practical choices to be
incorporated into PoC devices [52]. Fluorescent biosensing is often desirable in testing
dilute samples since fluorometers offer background-free detection, which aids in
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amplifying the signal-to-noise ratio and the already enhanced output signals that resulted
from cleavage [53]. This variety of sensing methodologies makes CRISPR a versatile tool,
capable of combining with other powerful tools such as LSPR. Introducing Cas proteins to
the surface of LSPR nanostructures takes advantage of the high customizability of CRISPR
complexes and the enhancement capability of the nanoparticles, resulting in a highly
sensitive and accurate system for nucleic acid detection This method also offers a labelfree detection method that provides the advantage of simplifying the required sample
preparation.

33

3.0

Fabrication of Microfluidic Cell

3.1

Development of the AuNM substrate
For the label-free capture of AuNPs, a unique system was fabricated. This AuNM

substrate was created using multiple microfabrication techniques [23]. These nanoscale
geometries were constructed on a SiO2 substrate that was pretreated with acetone and
isopropanol. To this surface, a thin Au film
was deposited at a thickness of 4 nm using
electron beam vapor deposition (KE604TT1TKF1, Kawasaki Science) [23]. This was done
at a rate of 0.1 − 0.2 Å s-1. The film then underwent an annealing process at a temperature
of 560°C for three hours, which caused the film to form randomly dispersed Au nanoislands
(AuNIs) across the SiO2 layer [23]. These AuNIs function as the cap of the AuNMs and
enable the use of LSPR as opposed to SPR enhancement since the AuNI is similar to that
of a nanosphere. The annealing process has another function in anchoring the new particles
into the surface of the SiO2 which helps to prevent liftoff during later fabrication
processing, as well as experimentation. Following the annealing process, the exposed SiO2
was removed by reactive ion etching (RIE) with
SF6 gas flowing at a rate of 45 sccm and 10
mTorr (Plasmalab 100, Oxford Instruments)
[23]. This gas selectively etched off the SiO2
while ignoring the gold component, leaving only
the substrate directly underneath the anchored
AuNIs remaining. The resulting structures
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formed the stems for the AuNMs that can be seen in Figure 13. The unique geometry
allowed for highly sensitive LSPR detection across the surface. Using a nanosphere-like
structure provided a greater area of conjugation for the additional AuNPs to adhere, while
the solid stem adhered to the sphere to create a robust physical device. Other methods for
periodic AuNM fabrication were reported using electron beam lithography to form AuNI
arrays, but for this work randomly-ordered structures sufficed [23]. Future experimentation
could lead to the incorporation of the ordered structures for more sectional testing.
3.2

Forming the PDMS device
The AuNM substrate mentioned above was sealed within a microfluidic chamber

comprised of a polydimethylsiloxane (PDMS) mold which was adhered to a common glass
slide. The combination of both components provided a vessel capable of containing
solutions for surface treatments onto the AuNMs. For the formation of the PDMS
component, a silicon elastomer base was mixed with a curing agent (SYLGARD 184) in a
10:1 ratio and was slowly poured over a 3-D printed resin mold that had been placed in a
90 mm glass petri dish. The resin mold used was prepared via 3-D printing (Form2,
Formlabs) and was used to create a square cutout in the PDMS. This square was 2.2 x 2.2
x 4 cm in order to house the AuNM chip that was 2 x 2 cm, while allowing for space above
the substrate for fluid flow. After covering the resin mold in the PDMS solution, the petri
dish was placed under vacuum for 30 minutes to ensure there were minimal air bubbles
trapped within the PDMS, as this could create cavities and affect the performance of the
microfluidic cell later on. The petri dish was relocated to an oven after the vacuum, where
it was exposed to 75°C heat for approximately five hours. This step was originally
performed at 100°C for one hour, but at higher temperatures the resin begun to warp which
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affected the quality of the PDMSglass seal for all future samples.
Following the oven treatment, the
PDMS was cut from around the
ultrasonic bath. The cleanings
were

performed

at

room

temperature for five minutes in two different passes; once in a solution of acetone, followed
by a 50/50 ethanol and deionized (DI) water mixture. Into the square cutout on the PDMS
layer, two 1 mm holes were punched into opposing corners. These holes were fitted with
10 cm long, 1 mm diameter surgical tubing, which is visible in Figure 14 as the inlet and
outlet. A syringe was fitted into the tubing and used to control the inlet and outlet fluid
flow. During the course of early experimentation, leakage was quite common between the
PDMS shell and glass slide. These events would cause substantial portions of the sample
solution to be wasted, affecting results. To combat this, the surface of the glass slide and
the PDMS layer were exposed to an oxygen plasma which created hydroxyl groups on the
surface that aided in creating a fluid-tight seal between the two components. Following
this, extra PDMS was occasionally cured along the contact point between the layers to
further aid in creating the seal. In order to keep the AuNM substrate adhered to the glass
slide, a 2 x 2 cm portion of double-sided tape was cut and added to the plasma-exposed
glass slide. It was important to ensure that nothing came into contact with the topside of
the AuNM as it was being placed onto the tape so that the nano-geometries remained intact.
At this point, the PDMS mold was placed over the AuNM chip and onto the glass slide.
The total cell was placed onto a hot plate at 125°C overnight to seal the PDMS to the glass
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slide. The end result was a liquid-tight chamber with a total volume of 240 μL that was
able to hold the test fluids and the AuNM substrate.
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4.0

Optimization of Surface Binding

4.1

Preparation of Reagents
For this work, streptavidin-coated 40 nm AuNPs (nanoComposix Inc.) suspended

in 1.0x PBS, 0.5% BSA, 0.05% Azide were used for most experiments. Other tests
incorporated bare (citrate-coated) AuNPs with diameters ranging from 4 – 200 nm and
concentrations varying from 0.115 nM to 9.26 μM. These solutions were all adjusted to 1.1
nM before being added to the device, unless otherwise stated. The bare 40 nm AuNPs
(nanoCompsix Inc.) were suspended in an aqueous 0.02 mM sodium citrate solvent, while
the 4 nm, 100nm, and 200 nm nanoparticles (Luna Nanotech) were suspended in water
with 0.01% Tween-20. In some later experiments, the bare 40 nm particles were extracted
from the citrate solutions and resuspended in DI water through a solvent exchange process.
This was done for a 10 μL sample placed in a centrifuge at 1500g for 45 minutes, as
recommended by nanoComposix Inc. The supernatant solution was then removed and
replaced with an identical quantity of nuclease-free water (NFW). To resuspend the
particles, the vial was vortexed until the aggregate particles disappeared.
4.2

Early Protocols
The initial design for this work was to form AuNP-AuNM couples that were linked

with a DNA strand that could then be cleaved by CRISPR-Cas12a proteins. This protocol
was a newer single-step binding protocol developed to link two AuNPs but was altered for
our system [56]. To achieve this, 240 μL of poly (A)-tagged DNA probes were added to
the surface of the substrate before being immediately exposed to a -20°C freezer for 70
minutes. After the device thaws, the surface was washed with 730 μL of PBS buffer three
times. The washings were performed to ensure the removal of any unbound probes or other
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material from the surface to certify later measurements were accurate to the actual
conditions on the AuNMs. This washing protocol was refined in later iterations for forming
the AuNP-AuNM couple by adding a syringe pump (SP2201 World Precision Instruments)
that controlled the flow rate of PBS. A faster speed would have the potential to dislodge
weakly bound components, altering the results, instead of simply removing unbound
probes. For this DNA linkage protocol, the DNA was first labeled with fluorescein amidites
(FAM) dyes instead of a biotin linker. Therefore, the fluorescent intensity of the washing
solutions was able to be tested to observe a decrease in intensity as a way of verifying the
binding of the probes to the AuNM structures. This was shown in Figure 15 where after
the first wash with PBS, the second and third wash had a fluorescent intensity comparable
to that of a blank cuvette. Even the fluorescent intensity of the first wash was less than onetenth of the initial DNA probe solution, indicating that the binding protocol was effective
for DNA. In Figure S2 the intensity of the pure DNA probe solution can be seen with a
fluorescent intensity around 10,000 units compared to the washing solutions shown here.
After this confirmation, the AuNPs
were added according to the
protocol to construct the AuNPDNA-AuNM

link.

A

similar

biotinylated-DNA strand was used
to bind to the streptavidin coating
of the AuNPs. To a 20 μL sample
of AuNPs, 5 μL of 1 μM
biotinylated-DNA was added in an
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off-chip tube and mixed. This ratio was based on the approximate number of binding sites
within the streptavidin molecules on the surface of the nanoparticles, as reported by
nanoComposix Inc. The resulting solution was added to the microfluidic cell and incubated
and washed following the procedure mentioned above. After the washing step, the AuNMs
were removed from the PDMS shell and double-sided tape and allowed to air-dry overnight
in a covered petri dish. This was done to evaporate any remaining solution that could alter
the local RI surrounding the unique structures. Comparing the absorption spectra of the
substrate before and after the addition of the AuNP-DNA complex exhibited a large redshift
in the peak wavelength value. For further confirmation of the construction of the coupling,
the same protocol was run without the DNA linker. To our surprise, the resulting absorption
spectra produced a near identical redshift, implying that the AuNPs were nonspecifically
binding to the AuNM without the need for a linking component.
The nonspecific formation of the AuNP-AuNM couple was originally combatted
by changing the protocol to a more established salt aging method previously used to form
AuNP aggregates [57]. For this method, 10 μL of AuNPs were added to 2.5 μL of tris(2carboxyethyl)phosphine (TCEP) along with 2.5 μL of the 1 μM biotinylated-DNA. The
volumes were halved to allow room for the TCEP, and NaCl solutions later. The TCEP
molecule has a high binding affinity for gold, which would help coat the exposed portions
of the AuNP and prevent aggregation with the AuNM. The solution was incubated for two
hours at room temperature before being mixed with 135 μL of NFW. The new solution was
incubated on-chip for twelve hours at room temperature. After this, 20 μL of NaCl solution
was added once each hour for five hours, followed by a ten second sonication. The salt
solution was added to neutralize the charge of the system in hopes of preventing
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aggregation of the AuNPs. This procedure can be found in more detail in section 9.3 of this
work along with other supplementary information. The final cell was wrapped in parafilm
to prevent evaporation and set aside for 24 hours before following the previously
mentioned washing and measurement procedure. It was observed that without the parafilm,
NaCl solution would flow out of the inlet and outlet holes due to capillary action. The
results of the salt-aging protocol showed comparable results to that of the single-step
binding, where the AuNPs directly couple with the AuNM surface which was undesirable
at the time.
A final protocol was developed that employed thiol-binding to link the AuNP to the
substrate. This procedure can be seen in section 9.3 along with the supplementary
information at the conclusion of this work. The new approach expanded upon the salt-aging
procedure previously discussed but employed biotin-ssDNA-thiol modified probes as
opposed to the normal biotinylated-DNA [58]. The probes were designed following the
thiol strands used in common literature [58]. For forming the AuNP-AuNM couple, the
thiol group was added to preferentially bind to the AuNM while the biotin would bind to
the streptavidin coating on the AuNPs. The new variation on the binding protocol still
resulted in the same conclusion as the two previous protocols where the AuNPs would bind
onto the AuNM regardless of the DNA presence. The three methods above failed to develop
the AuNP-DNA-AuNM coupling that was initially desired for CRISPR cleavage. This
failure led to further investigation of the AuNP aggregation on the AuNM structures which
required a new direct addition protocol to investigate the effects.
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4.3

Direct Addition Protocol
After observing the large-scale redshift produced by the addition of the AuNPs, the

project changed direction to investigate this phenomenon further. For this, a new direct
addition protocol was developed for the formation of a linker-free AuNP-AuNM couple.
This procedure is described in detail in section 9.4. In the first version of this method, 7 μL
of AuNPs were conjugated with 0.5 μL of 100 μM FAM-DNA-biotin for 30 minutes on a
shaker before being added to the microfluidic cell. The DNA was used to link the AuNPs
to other components in various applications, making the system customizable. The effect
of the DNA strands on the detected redshift
was evaluated by applying a solution
containing only the ssDNA, with no
statistically

significant

shift

detected.

Therefore, if the DNA was to be omitted
from the test, 7.5 μL of AuNPs were diluted

Figure 16: Diagram for the addition of
AuNPs to the microfluidic cell.

in 222 μL of NFW before finally being added to the AuNM surface which was subsequently
wrapped in parafilm to prevent further evaporation or contamination during incubation.
The solution was allowed to rest on the surface of the substrate for twelve hours at room
temperature before undergoing the original washing procedure with 730 μL of 1x PBS
buffer at a rate of 146 μL/min three times. The system used to measure the absorbance of
the surface was custom built for this application and is shown in Figure S1 and explained
in section 9.2. This procedure was adapted for later experiments to include changes in
concentration, diameter, and the coating on the AuNPs.
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5.0

Analysis of the Surface Condition
The binding of the AuNPs to the surface of the AuNMs caused a change in the local

refractive index which resulted in the redshift observed in the peak wavelength for the
adsorption spectra. These AuNPs formed clusters surrounding the AuNM which produced
strong “hotspots” that provide the resulting LSPR effect. To demonstrate the wavelength
delta, the absorption spectra were measured
before and after the addition of AuNPs, which
resulted in a 30 nm redshift as evident in Figure
17. This also resulted in an increased absorbance
in samples that had AuNPs (1.1 nM) introduced
to

the

system.

All

peak

resonant

delta

measurements shown are an average of at least
three sites across the surface of the AuNM chip
with the appropriate error bars applied.
The capability of the LSPR system was investigated further by measuring the
wavelength shift of AuNPs with different diameters ranging from 4 to 200 nm, all with
fixed concentrations at 1.1 nM. Based on the results, the 40 nm AuNPs produced the
greatest redshift (~30 nm). In contrast, the smaller 4 nm particle produced a minor redshift
of ~11 nm. The effects of diameter on the magnitude of the redshift can be seen in Figure
18 where the 4 and 40 nm particles, as well as the 100 and 200 nm particles, are
summarized. For the larger two particles, their addition resulted in a redshift of
approximately 25 and 23 nm, for the respective 100 and 200nm AuNPs. These results
showed that there was an optimal size constraint on the AuNP-AuNM couple. The smaller
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particles produced a smaller wavelength shift
due to weaker LSPR interactions. The resulting
“hotspots” could not produce as strong of an
enhancement factor to the incoming photons. It
would be expected that the larger AuNPs would
produce a larger wavelength delta, but instead

Figure 18: Effect of AuNP diameter on resulted in a smaller redshift. This is due to the
the apparent redshift in resonant
wavelength.
formation of aggregates which were easily
dislodged by the washing procedure. The clusters formed by these two larger particle sizes
could be seen visibly aggregating, as well as flowing off the surface of the AuNMs under
the forces of the PBS washing.
To further determine the optimal conditions for forming the coupling, the coating
on the AuNP was investigated. For this experiment, the streptavidin-coated 40 nm AuNPs
were compared to two varieties of bare (citrate-coated) 40 nm AuNPs. The two bare
particle samples differed in their carrier
solution from a dilute sodium citrate stock
solution to a DI water solution. This was done
using a carrier exchange procedure suggested
by nanoCompsix Inc. as described earlier in
section 4.1. For the bare particles, a lesser 9
nm and 12 nm redshift were observed in the
respective solutions, while the streptavidincoated AuNPs produced the 30 nm wavelength
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shift mentioned previously. These results can be seen in Figure 19 where the streptavidin
AuNPs produced a three times greater redshift. The smaller redshift resulting from the bare
AuNPs is due to the presence of the citrate molecules, which are charge neutralizing and
used to prevent aggregation of AuNPs while in storage [59]. This would further prevent
the formation of aggregates surrounding the AuNMs, which resulted in a weaker
wavelength shift. For the bare AuNPs in DI water, there still remained a small fraction of
the citrate molecules present as not all the fluid could be exchanged. The citrate molecules
also remained weakly adhered to the surface even in the DI water, which further prevented
the formation of the desirable aggregates. Since this was a linker-free addition, the citrate
molecules were not displaced by anything and left weakly associated. Therefore the 40 nm,
streptavidin-coated AuNPs offer the greatest advantage and the highest binding efficiency
of all tested samples, resulting in a 30 nm redshift in adsorption peak wavelength value.
A final test was performed to
determine the effect of concentration on the
microfluidic system. From concentration
testing, it was determined that the 30 nm
wavelength

shift

was

observable

at

concentrations greater than 500 pM which
can be seen in Figure 20. Concentrations
including 1000 pM, 750 pM, and 500 pM
were tested to verify the maximum
perceptible wavelength shift and demonstrated that the value plateaus around 30 nm. As
concentration decreased below 500 pM, the magnitude of the redshift decreased following
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an approximate S-curve. At a concentration of 250 pM and 100 pM, the wavelength delta
was 18 nm and 15 nm, respectively. These low concentration values could occasionally
produce the high ~30 nm shift, but it was inconsistent across multiple samples. As the
concentration decreased, the difficulty in exactly locating the AuNP clusters surrounding
a AuNM drastically increased since fewer aggregates would form altogether. The clusters
that did form would contain fewer particles than at higher concentrations which diminishes
the collective oscillation of AuNPs in large multimers, resulting in a weaker LSPR effect.
For higher concentrations of AuNPs, a maximum redshift of 30 nm was the result of
limiting available space surrounding the AuNMs. At higher concentrations more clusters
would form around more AuNMs, but the size of the clusters would reach a maximum
value. This means higher concentrations above 500 pM are easier to detect but do not
produce a stronger wavelength delta as the value increases.
The formation of the clusters was verified by scanning electron microscope (SEM)
imaging. In these images, the AuNP-AuNM coupling is easily observable as small 40 nm
particles are visible in the post imaging (Figure 21, right) but only in close proximity to
that

of

the

AuNM.

These

particles are missing in the
images

taken

introduction

of

before
the

the

AuNPs
100 nm

100 nm

100 nm

100 nm

100 nm

100 nm

100 nm

100 nm

(Figure 21, left), further helping
to verify the formation of
desirable aggregates.
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6.0

Verification of Binding via Simulations and Modelling
The binding event studied by the above results was further confirmed by 3-D finite-

difference time-domain (FDTD) simulations. Here, the system was modeled for a single
AuNM, constructed as a hemispherical cap located on a pillar of equal diameter, with a
maximum of six uncoated AuNPs surrounding the structure using a commercial software
package (Lumerical Inc.). These particles were randomly oriented to mimic the actual
binding of the AuNPs. To achieve this, the AuNPs and AuNM were set at fixed diameters
of 40 nm and 100 nm, respectively. The AuNM diameter was approximated based on the
average size gathered from the SEM images in Figure 21, while the AuNPs have far less
deviation and were consistently 40 nm in diameter.
From the 3D modeling, a simulated absorption spectrum was produced for a AuNM
surrounded by 0, 1, 2, 4, and 6 AuNPs. From this plot shown in Figure 22 (middle), the
bare AuNM showed a similar peak value to that of our actual substrate at approximately
580 nm. When 1 and 2 AuNPs were introduced a shift less than 10 nm was observed. This

16

3

2

5
4
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coincides with the experimental values shown for lower concentrations of AuNPs. At these
low concentrations, smaller clusters are likely to form and at farther distances from the
3AuNM, such that the resultant redshift will be smaller than that for higher concentrations.
The simulation model accurately supports the experimental result seen for small clusters
or dimers producing a miniscule shift with sparse simulated AuNPs exhibiting a similar
minute shift. The simulations containing the 4 and 6 AuNPs produced a drastic redshift in
peak wavelength, approaching 70 nm in magnitude. These conclusions are similar to that
of the experimental results for large groupings and clusters, but to a greater extent. The
difference in redshift is due to multiple factors, with the greatest factor being the AuNPs
lacked the streptavidin coating. The coating on the experimental particles increased the
spacing between the AuNP-AuNM coupling which is directly correlated to the strength of
the hotspot and the magnitude of the resulting peak wavelength change [14]. Another
difference that influenced the larger shift is the single AuNM pillar, which can ignore any
effects due to surrounding nanostructures that could alter the localized RI. As well as the
presence of remaining PBS molecules from the washing protocol which can have an effect
on the RI and the incoming light. For the simulations with a greater number of AuNPs, the
broadening effect becomes prominent as previously mentioned. This helps to further
support the experimental data along with the SEM imaging, where the clusters were
observed. Since particles can resonate in-phase or out-of-phase, these larger clusters
undergo higher-order oscillations resulting in the broadening effect observed both
experimentally and from the simulations [60]. Taking the experimental spectra from the
concentration testing and applying a normalized unit, the increase in broadening is obvious
at higher concentrations (Figure 22, right). The normalized unit was calculated by taking
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the full width at half maximum (FWHM) value and dividing it by the peak intensity value.
From this, as the concentrations increased, the normalized unit grew which indicates a
broader spectrum at these greater concentrations. This follows the same trend observed by

Z pos (nm)

Y pos (nm)

Z pos (nm)

the simulated spectra for the increasing AuNP number.

X pos (nm)

X pos (nm)

X pos (nm)

Electric field distribution maps were also modeled for the same AuNP-AuNM
system as described above, but with only three surrounding particles. This method provides
a technique used to observe the location of intense electric fields, or the “hot spots”
previously described which in Figure 23 are illustrated by the dark red spots. These images
were formed based on linear polarization of the electric field from incoming photons, taken
for cross-sections of the nanostructures at peak wavelength values of 623 and 631 nm. For
this, the light underwent polarization on the x-axis or at a 45 degree angle. Focusing on the
hotspots, an increased electric field intensity is observed between AuNPs bound in close
proximity to the AuNM. As the distance between the two particles grows, the intensity
decreases as shown by the change from the dark red color to a yellow hue. The shift in
color coincided with a weaker “hot spot” where a lesser LSPR effect would be observed.
As this was modeled using bare AuNPs, they were able to be located in closer proximity
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than that of the actual experimental particles. Therefore, hotspots observed here were
stronger and would produce a greater enhancement factor and redshift.
A final verification for the experimental conclusion was done through modeling the
AuNP-AuNM coupling as a plasmonic ruler system. Noted below as equation 1, the
formula was developed to calculate the wavelength delta that would result from particles
ሺ− 𝑠Τ𝐷 ሻ
𝛥𝜆
= 0.12 exp ቊ
ቋ
𝜆0
0.16

(1)

with

a

known

separation

[61,

interparticle
62].

This

equation has been adapted for
AuNP-AuNP coupling, as well
as AuNP-Au film binding events
[61,62]. Here, the AuNMs were
treated

as

AuNPs

for

the

relevant decay constant, as the
advantage
Figure 24165: The calculated wavelength delta from
interparticle separation based on the plasmonic ruler
equation (Eqn #1).

nanoscale

of

the

geometries

unique
is

a

constrained AuNP that provides

more surface area than a gold film, but the stabilized advantage of a substrate [23]. For this
application, the interparticle separation is unknown since the binding of the AuNP to the
AuNM is a direct addition method that is a linker-free application. Therefore, the AuNP is
randomly bound to the substrate with an affinity for the AuNM, not at an exact controlled
distance. From this, the interparticle separation is calculated with a known delta
wavelength of 30 nm. The particle diameter was set at 40 nm, and the initial wavelength
of the system was 580 nm which is the average resonant peak for the AuNM substrate. This
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initial value varied slightly between samples due to differing characteristics in the SiO2
substrate. As mentioned previously, the decay constant was set for a AuNP dimer at 0.16
with a universal trend constant of 0.12 for AuNPs [62]. Based on the equation for a 30 nm
wavelength shift, the according interparticle separation would be approximately 5 nm. This
can be seen in Figure 24 where the known wavelength delta accurately matches the
interparticle separation for a streptavidin coating. An approximate 5 nm hydrodynamic
diameter on the surface of a AuNP was due to the streptavidin molecule which was used
for these experiments [63]. Therefore, the modeling for the plasmonic ruler with the AuNP
and AuNM system corresponded accurately with the experimental results produced from
the LSPR hot spots. This, in combination with the FDTD method and electric field
distribution map modelling aids in supporting the conclusions drawn by the experimental
results.
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7.0

Demonstration of System for Detecting a Viral Target

7.1

Preparation of CRISPR Reagents
For proving an application of the microfluidic cell, Lbu-Cas13a proteins were

employed to combine the advantageous effects of LSPR with CRISPR. This protein was
prepared from a previous protocol as published and described [64]. For the CRISPR
application, SARS-CoV-2 (703 nucleotides) spike genes were used as the positive target,
while the SARS-CoV-1 (660 nucleotides) virus was used as the negative control alongside
a sample with no target present. Both viruses were amplified from plasmids pUC57-SARSCoV-1 and pUC57-SARS-CoV-2. This system used the same streptavidin-coated 40 nm
AuNPs (nanoComposix Inc.) in combination with Dynabeads™ MyOne™ Streptavidin C1
(Thermal Fisher Scientific Inc.), also referred to as magnetic beads (MB) with a diameter
of 1 µm. The RNA reporters and guide RNA used were acquired from IDT Inc. (Table S1)
while the biotinylated anti-fluorescein antibodies (1 mg/mL) used were purchased from
Vector Laboratories Inc.
7.2

Adaptations for the CRISPR Application
A final change was made to the direct addition protocol for the testing of an off-

chip CRISPR-Cas13a procedure where the AuNPs were conjoined to a MB via FAMssRNA-biotin linkers. The CRISPR-LSPR combination is demonstrated by the schematic
in Figure 25 where a ssRNA reporter probe, labeled with a FAM and biotin component on
opposing sides, was used for the formation of the AuNP-RNA-MB complex. In the
presence of the target SARS-CoV-2 strand, the CRISPR-Cas13a complex binds to the
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target RNA which promotes the collateral cleavage ability of the protein. This separated
the FAM dye from the biotin by breaking the ssRNA reporters. The addition of AuNPs with
a streptavidin coating favor binding to the biotin linker, which in the presence of the target,
was previously separated from the FAM linker. Once the MBs are suspended, they
preferentially bind to the FAM labels from the broken RNA probes. Without the SARSCoV-2 target, the AuNP becomes linked to the MB with the probe conjoining them.
Following this, the MB was isolated on the sidewall of the test vial using a magnet and the
remaining supernatant solution was extracted. The supernatant solution was then diluted
following the direct addition protocol for on-chip testing of the AuNM substrate seen in
section 9.5. If the probe is cleaved by the presence of the target, the AuNPs are not isolated
on the side wall since they are not adhered to the MB, and therefore left suspended in the
supernatant. The presence of the AuNPs allow for positive identification of the target by
detection of the resonant wavelength shift as described previously. If no wavelength shift
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was observed, the AuNPs were not separated from the MB which indicates a lack of
cleavage from the CRISPR-Cas13a protein and a lack of viral target in the sample.
7.3

Identification of the Viral Target
The experimental results gathered from the CRISPR testing demonstrated that the

system was able to positively identify the SARS-CoV-2 target strand by a 23 nm redshift.
The resulting shift was much larger than that of a similar non-target strand in SARS-CoV1 and a negative control which showed a 12 nm and 10 nm redshift respectively, which can
be seen in Figure 26. The ability to differentiate between the two RNA strands shows the
specificity of the Cas13a protein to distinguish SNV, as well as produce a positive result
far greater than the control sample. Both negative
samples still exhibited a small redshift due to
imperfect isolation of the MBs which still
allowed for low concentrations of AuNPs to be
added to the surface of the plasmonic chip. The
magnitude of the SARS-CoV-2 redshift was
lesser than that of the previous tests due to the
portions of ssRNA that were attached to the biotin

Figure 26: The resulting redshift from
the CRISPR application for samples
containing target RNA sequences.

label. The biotin would adhere to the streptavidin layer and further separate the AuNP from
the AuNM, as demonstrated by the plasmonic ruler modeling. Other reasons could be the
presence of the cleaved components, MBs, or the Cas13a protein in the supernatant that
would alter the RI and diminish the strength of the LSPR effect between the AuNP and
AuNM couple.
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8.0

Conclusion & Future Work
Through this work, a highly sensitive microfluidic cell that was able to accurately

detect ultra-dilute concentrations of AuNPs was developed. Incorporating a simplified
direct addition protocol, it was possible to bind particles to unique nanoscale geometries
constructed on a substrate, referred to as AuNMs. The system is able to positively identify
the presence of AuNPs on the surface through LSPR detection, which takes advantage of
changes in the local RI surrounding the substrate. The physical phenomenon investigated
in this work provides a drastic enhancement to incident photons applied to the surface,
which allow for the absorption spectrum of AuNPs with a concentration as low as 100 pM
to be detected far above the background noise of spectrometers. The optimal conditions for
AuNP addition, as gathered by this work, include concentrations greater than 500 pM for
consistent results with a resonant shift greater than 30 nm. Other key parameters include
the use of 40 nm AuNPs which exhibited the greatest redshift when compared to particles
with a diameter of 4 nm, 100 nm, and 200 nm. As well as the streptavidin coating on AuNPs
which was preferable to the bare AuNPs that were suspended in a sodium citrate solution.
The bare particles would offer a greater redshift, but the charge neutralizing citrate
molecule limited the aggregation and made them unusable particles for this application.
The customizability of the LSPR binding allows for a variety of applications of the
microfluidic cell. In this work, we combine the unique advantages of LSPR biosensing
with a CRISPR-Cas13a complex for the detection of the SARS-CoV-2 RNA target. The
combination of these two techniques forms a novel device that takes advantage of both of
these unique methods for the first time. The use of the Cas13a protein provides the
advantage of collateral cleavage to further increase the sensitivity of the system as well as
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high specificity in discerning between SARS-CoV-2 and SARS-CoV-1 due to nucleotide
variations.
To further understand the CRISPR application, the future work will investigate the
effects of concentration on the cleavage capability of the Cas13a protein. Understanding
the role of the ssRNA concentration will help determine the limit of detection for the offchip cleavage before applying the supernatant to the AuNM substrate. Thereby uncovering
the capabilities of the LSPR system for the dilute detection of viral targets. Focusing on
the AuNP-AuNM cleavage, future experiments could be done to investigate the effect of
particle shape on the resonant wavelength shift. Gold nanorods or nano-urchins might be
able to increase the redshift due to the aspect ratio or spikes being able to achieve closer
proximity or packing surrounding the AuNM.
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9.0

Supplemental Information

9.1

Microfluidic Cell Fabrication
The device was constructed from PDMS adhered to a glass substrate. The PDMS was

formed by mixing 50 g of silicon elastomer base with 5 g of curing agent (SLYGARD 184)
in a 10:1 ratio. This was poured over the resin mold in a petri dish. The mixture was added
to a vacuum chamber for 30 minutes to remove all air bubbles that were introduced by the
mixing. Following this, the petri dish containing the PDMS mixture was added to an oven
at 75°C for 5 hours. This may take a longer heating time depending on the hardness of the
PDMS before removing the resin mold with an X-acto knife. The PDMS was cut to the
exact size of the resin mold, approximately 4 x 4 cm. This PDMS mold was immediately
washed in acetone and a 50/50 ethanol and DI water mixture in two separate passes through
an ultrasonic bath for 5 minutes. A glass slide underwent an identical washing procedure.
Both samples were dried with a blast of air before being treated with an O2 plasma for 15
seconds on the surfaces of the PDMS and glass that will be in contact with one another.
The PDMS layer had two 1 mm holes punched into opposing corners of the molding to
function as the inlet and outlet ports. Before adherence of the PDMS to the glass backing,
a 2 x 2 cm portion of washable double-sided tape is cut and used to hold the AuNM chip
in place within the cell. The PDMS is finally used to cover the AuNMs and adhered to the
glass substrate while on a 125°C hot plate for 24 hours. The total volume remaining in the
chamber was 240 μL which was used for the experimental solutions.
9.2

Absorbance Setup Construction
The system used to detect the absorbance spectrum for the AuNM substrate was

constructed within our lab from a halogen light source, an ocean optics spectrometer, and
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a set of filters. This included a UV-Vis collimating lens, a dielectric broadband mirror, and
a short-pass filter. A collimating lens is used to orient the light beams into a parallel
orientation, while the short-pass filter is responsible for blocking longer wavelengths and
allowing shorter wavelengths to pass through, such as the visible spectrum, used in this
application. The dielectric broadband mirror was used to reflect all light to ensure a greater
percentage of light makes it to the surface of the AuNMs. The light source introduces
photons to the surface of the AuNM system while the detector is underneath the stage,
detecting the light that passes through the plasmonic chip.
9.3

Thiol and Salt Aging Protocol
1.

Add 1 μM biotin-ssDNA-thiol modified probes (2.5 μL) to 1.1 nM of AuNP
solution (10 μL) for 30 min mixing step
•
•

/5Biosg/ TT TCT GTC GCG CTT TTT /3ThioMC3-D/
40 nm streptavidin coated AuNPs

Treat 1 μM thiol-oligonucleotides-AuNP with 100 μM TCEP (2.5 μL) for 2 hrs
@ 25C
3. Apply reduced thiol-DNA with nuclease-free water (135 μL) to the AuNM for
12 hrs @ 25°C
4. Add 20 μL of 1 M NaCl five times at 1 hr intervals
2.

5.
6.
7.

•

Following each addition, sonification of the device for 10 s

•

Add .05% Tween20 for stabilizer (Was not added for following data)

Store @ 25°C for 24 hrs
Wash 3 times (730 μL/ each time) with buffer (0.01 M phosphate buffer, pH 7.4)
Allow the samples to dry before recording absorbance measurements
•

9.4

Store at -20C while not in use to prevent degradation and altercations to the surface
condition

Direct Addition Protocol
1.

Add .5 μL of FAM DNA (100 μM) to 7 μL of 40 nm Strep GNP (1.1 nM) and set
on shaker for 30 mins
•
•

If diluting, take .75 μL and dilute in DI water to desired concentration (i.e., 6.75 μL for
1:10 concentration)
If final dilution volume is greater than 7.5 μL, separate out 7.5 μL for next step

Treat 1 μM thiol-oligonucleotides-AuNP with 100 μM TCEP (2.5 μL) for 2 hrs
@ 25°C
3. Add nuclease-free water (232 μL) to DNA-AuNP solution (7.5 μL) following by
mixing with the vortex to ensure uniformity
2.

•

Vary water volume as necessary: total volume should equate to ~240 μL
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4.

Apply mixture through inlet of plasmonic system for incubation overnight (~12
hrs @ RT) and wrap in parafilm to prevent evaporation or leakage
•

5.

Wash 3 times (730 μL/ each time) with 1x PBS buffer (0.01 M phosphate buffer,
pH 7.4)
•
•

6.

9.5

Add 30 min mixing step here as required for experiments

Washed using mechanical pump at a flow rate equal to 146 μL/min
First 250 μL collected in the first wash to observe color change before and after addition

Allow the samples to dry before recording absorbance measurements
Tables and Figures

Figure S1. Schematic to illustrate the absorbance setup, including filter, light source, and
stage. This used a light source on the surface of the chip with the detector underneath.
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Figure S2. Graph to illustrate the fluorescent intensity of the DNA probe solution
compared to washing solutions containing FAM-DNA probes and 1x PBS solution. Inset
focuses on the three washing volumes for greater detail.
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Table S1. Target RNA, crRNA, RNA reporter sequence.
Name

Sequence

Sources

Fragment of
plasmids
pUC57-SARSCoV-2

UUAUGUCCUU CCCUCAGUCA GCACCUCAUG GUGUAGUCUU
CUUGCAUGUG ACUUAUGUCC CUGCACAAGA AAAGAACUUC
ACAACUGCUC CUGCCAUUUG UCAUGAUGGA AAAGCACACU
UUCCUCGUGA AGGUGUCUUU GUUUCAAAUG GCACACACUG
GUUUGUAACA CAAAGGAAUU UUUAUGAACC ACAAAUCAUU
ACUACAGACA ACACAUUUGU GUCUGGUAAC UGUGAUGUUG
UAAUAGGAAU UGUCAACAAC ACAGUUUAUG AUCCUUUGCA
ACCUGAAUUA GACUCAUUCA AGGAGGAGUU AGAUAAAUAU
UUUAAGAAUC AUACAUCACC AGAUGUUGAU UUAGGUGACA
UCUCUGGCAU UAAUGCUUCA GUUGUAAACA UUCAAAAAGA
AAUUGACCGC CUCAAUGAGG UUGCCAAGAA UUUAAAUGAA
UCUCUCAUCG AUCUCCAAGA ACUUGGAAAG UAUGAGCAGU
AUAUAAAAUG GCCAUGGUAC AUUUGGCUAG GUUUUAUAGC
UGGCUUGAUU GCCAUAGUAA UGGUGACAAU UAUGCUUUGC
UGUAUGACCA GUUGCUGUAG UUGUCUCAAG GGCUGUUGUU
CUUGUGGAUC CUGCUGCAAA UUUGAUGAAG ACGACUCUGA
GCCAGUGCUC AAAGGAGUCA AAUUACAUUA CACAUAAACG
AACUUAUGGA UUUGUUUAUG AGA

Synthego

Fragment of
plasmids
pUC57-SARSCoV-1

UUGUGUUUAA UGGCACUUCU UGGUUUAUUA CACAGAGGAA
CUUCUUUUCU CCACAAAUAA UUACUACAGA CAAUACAUUU
GUCUCAGGAA AUUGUGAUGU CGUUAUUGGC AUCAUUAACA
ACACAGUUUA UGAUCCUCUG CAACCUGAGC UUGACUCAUU
CAAAGAAGAG CUGGACAAGU ACUUCAAAAA UCAUACAUCA
CCAGAUGUUG AUCUUGGCGA CAUUUCAGGC AUUAACGCUU
CUGUCGUCAA CAUUCAAAAA GAAAUUGACC GCCUCAAUGA
GGUCGCUAAA AAUUUAAAUG AAUCACUCAU UGACCUUCAA
GAAUUGGGAA AAUAUGAGCA AUAUAUUAAA UGGCCUUGGU
AUGUUUGGCU CGGCUUCAUU GCUGGACUAA UUGCCAUCGU
CAUGGUUACA AUCUUGCUUU GUUGCAUGAC UAGUUGUUGC
AGUUGCCUCA AGGGUGCAUG CUCUUGUGGU UCUUGCUGCA
AGUUUGAUGA GGAUGACUCU GAGCCAGUUC UCAAGGGUGU
CAAAUUACAU UACACAUAAA CGAACUUAUG GAUUUGUUUA
UGAGAUUUUU UACUCUUAGA UCAAUUACUG CACAGCCAGU
AAAAAUUGAC AAUGCUUCUC CUGCAAGUAC UGUUCAUGCU
ACAGCAACGA UACCGCUACA

Synthego

crRNA
RNA reporter

GACCACCCCAAAAAUGAAGGGGACUAAAACgccagagaugucaccuaaau
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